Royal London Asset Management Ltd. Raises Stock Holdings in Molina Healthcare, Inc. (NYSE:MOH)

Royal London Asset Management Ltd. grew its stake in Molina Healthcare, Inc. (NYSE:MOH) by 1.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 50,743 shares of the company’s stock after buying an additional 483 shares during the quarter. Royal London Asset Management Ltd.’s holdings in Molina Healthcare were worth $14,769,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of MOH. True Wealth Design LLC grew its position in shares of Molina Healthcare by 2,500.0% during the third quarter. True Wealth Design LLC now owns 104 shares of the company’s stock worth $36,000 after purchasing an additional 100 shares in the last quarter. Versant Capital Management Inc grew its position in shares of Molina Healthcare by 83.1% during the fourth quarter. Versant Capital Management Inc now owns 163 shares of the company’s stock worth $47,000 after purchasing an additional 74 shares in the last quarter. Wingate Wealth Advisors Inc. purchased a new stake in shares of Molina Healthcare during the fourth quarter worth about $52,000. EverSource Wealth Advisors LLC grew its position in shares of Molina Healthcare by 81.5% during the fourth quarter. EverSource Wealth Advisors LLC now owns 196 shares of the company’s stock worth $57,000 after purchasing an additional 88 shares in the last quarter. Finally, Harvest Fund Management Co. Ltd grew its position in shares of Molina Healthcare by 895.0% during the fourth quarter. Harvest Fund Management Co. Ltd now owns 199 shares of the company’s stock worth $58,000 after purchasing an additional 179 shares in the last quarter. Hedge funds and other institutional investors own 98.50% of the company’s stock.

Insider Buying and Selling

In related news, Director Steven J. Orlando sold 1,000 shares of the firm’s stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $301.33, for a total transaction of $301,330.00. Following the completion of the sale, the director now directly owns 17,375 shares of the company’s stock, valued at approximately $5,235,608.75. This trade represents a 5.44 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 1.10% of the stock is owned by corporate insiders.

Molina Healthcare Price Performance

NYSE:MOH opened at $309.85 on Friday. The firm has a market capitalization of $16.95 billion, a price-to-earnings ratio of 15.17, a PEG ratio of 1.06 and a beta of 0.56. Molina Healthcare, Inc. has a 1 year low of $262.32 and a 1 year high of $423.92. The business has a 50 day simple moving average of $299.99 and a 200-day simple moving average of $309.37. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.62 and a quick ratio of 1.62.

Molina Healthcare (NYSE:MOH) last issued its quarterly earnings results on Wednesday, February 5th. The company reported $5.05 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $5.74 by ($0.69). Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. Equities analysts forecast that Molina Healthcare, Inc. will post 24.4 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research firms recently issued reports on MOH. Mizuho cut their target price on Molina Healthcare from $382.00 to $376.00 and set an “outperform” rating for the company in a research report on Monday, March 3rd. UBS Group cut their price target on Molina Healthcare from $374.00 to $325.00 and set a “neutral” rating for the company in a report on Friday, February 7th. JPMorgan Chase & Co. restated a “neutral” rating and set a $350.00 price target (down previously from $378.00) on shares of Molina Healthcare in a report on Tuesday, December 17th. Stephens restated an “equal weight” rating and set a $345.00 price target on shares of Molina Healthcare in a report on Thursday, February 6th. Finally, Wells Fargo & Company upgraded Molina Healthcare from an “equal weight” rating to an “overweight” rating and raised their price target for the company from $295.00 to $372.00 in a report on Wednesday, March 5th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $355.69.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.